Yilmaz Mahshid
Net worth: 201 662 $ as of 2026-05-30
Net worth: 201 662 $ as of 2026-05-30
Dr. Yilmaz Mahshid is a Chief Financial Officer at Egetis Therapeutics AB and an Independent Director at InDex Pharmaceuticals AB. He is on the Board of Directors at Medivir AB, InDex Pharmaceuticals AB and Mahshid Advisors AB. Dr. Mahshid was previously employed as an Investment Manager & Controller by Industrifonden, a Research Analyst by Pareto Securities AB, a Research Analyst by Pareto Öhman AB, and a Research Analyst by E.
Öhman J:or Fondkommission AB. He also served on the board at Flerie AB, Avidicare AB and Venaticus Capital AB. He received his doctorate degree from Karolinska Institutet.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-05-12 | 306,249 ( 0.07% ) | 201 662 $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| MEDIVIR AB | Director/Board Member | 2021-05-04 |
| EGETIS THERAPEUTICS AB | Director of Finance/CFO | 2021-05-31 |
InDex Pharmaceuticals AB
InDex Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Director/Board Member | 2020-03-31 |
Mahshid Advisors AB | Director/Board Member | - |
| Companies | Position | End |
|---|---|---|
Venaticus Capital AB | Director/Board Member | 2022-03-17 |
| EGETIS THERAPEUTICS AB | Director of Finance/CFO | 2020-08-31 |
Industrifonden
Industrifonden Investment ManagersFinance Industrifonden invests in companies located in the Nordic region. The firm targets companies operating in the fields of planetary health, life science, deep tech and transformative tech. It provides financing for seed and early stage capital requirements with an investment size of SEK 10 – 50 million. | Comptroller/Controller/Auditor | 2017-11-29 |
Pareto Securities AB
Pareto Securities AB Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 2015-04-30 |
Pareto Öhman AB
Pareto Öhman AB Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 2013-09-17 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 12 |
|---|---|
Medivir AB
Medivir AB Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Industrifonden
Industrifonden Investment ManagersFinance Industrifonden invests in companies located in the Nordic region. The firm targets companies operating in the fields of planetary health, life science, deep tech and transformative tech. It provides financing for seed and early stage capital requirements with an investment size of SEK 10 – 50 million. | Finance |
Karolinska Institutet
Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
E. Öhman J:or Fondkommission AB
E. Öhman J:or Fondkommission AB Financial ConglomeratesFinance Operates as a capital management company | Finance |
Flerie AB
Flerie AB Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for the treatment of inflammation and cancer diseases | Health Technology |
Egetis Therapeutics AB
Egetis Therapeutics AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Pareto Öhman AB
Pareto Öhman AB Investment Banks/BrokersFinance Provides brokerage services | Finance |
Pareto Securities AB
Pareto Securities AB Investment Banks/BrokersFinance Provides brokerage services | Finance |
Avidicare AB
Avidicare AB Medical DistributorsDistribution Services Provides products that reduces airborne bacteria and virus pollution at hospitals. | Distribution Services |
InDex Pharmaceuticals AB
InDex Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Venaticus Capital AB | |
Mahshid Advisors AB |
Select your edition
All financial news and data tailored to specific country editions